atracurium has been researched along with Chronic Kidney Failure in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jirasiritham, S; Tantivitayatan, K | 1 |
| Hunter, JM; Jones, RS; Utting, JE | 3 |
| Duvaldestin, P; Lavaud, E; Lebrault, C; Nebout, T; Strumza, P | 1 |
| Canfell, C; Castagnoli, K; Fahey, MR; Fisher, DM; Hennis, PJ; Miller, RD; Rupp, SM; Sharma, M | 2 |
| Boyd, AH; Eastwood, NB; Hunter, JM; Parker, CJ | 3 |
| Heine, P; Link, J; Papadopoulos, G; Wolter, J | 1 |
| Bovianska, N | 1 |
| Illner, WD; Nibler, R; Weninger, E | 1 |
| Dahaba, AA; List, WF; Rehak, PH; von Klobucar, F | 1 |
| Macrina, E; Nania, A; Rocca, MT; Verre, M | 1 |
| Berntman, L; Rosberg, B; Shweikh, I; Yousef, H | 1 |
| Blanloeil, Y; Cozian, A; Lepage, JY; Malinge, M; Pinaud, M; Souron, R | 1 |
| Gramstad, L | 1 |
| Colin, JN; Singlas, E | 1 |
| Brodzka, M; Gołebiowski, T; Lazowski, T; Mayzner-Zawadzka, E; Michałowski, P | 1 |
| Baude, C; Chabrol, B; Dubernard, JM; Mongin-Long, D; Moskovtchenko, JF; Renaudie, M; Ville, D | 1 |
| Boheimer, N; Dopson, TA; Simmonds, RJ; Ward, S; Weatherley, BC | 1 |
| Ward, S; Weatherley, BC | 1 |
6 trial(s) available for atracurium and Chronic Kidney Failure
| Article | Year |
|---|---|
Pharmacodynamics of the 1R cis-1'R cis isomer of atracurium (51W89) in health and chronic renal failure.
Topics: Action Potentials; Adult; Atracurium; Female; Humans; Isomerism; Kidney Failure, Chronic; Male; Middle Aged; Nerve Block; Time Factors; Ulnar Nerve | 1995 |
[The action of atracurium and vecuronium in chronically hemodialyzed patients].
Topics: Adult; Aged; Atracurium; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neuromuscular Junction; Renal Dialysis; Time Factors; Vecuronium Bromide | 1993 |
Atracurium and pancuronium in renal insufficiency.
Topics: Adult; Atracurium; Clinical Trials as Topic; Female; Humans; Kidney Failure, Chronic; Male; Neuromuscular Junction; Pancuronium; Random Allocation; Time Factors | 1989 |
Vecuronium and atracurium in patients with end-stage renal failure. A comparative study.
Topics: Adult; Atracurium; Dose-Response Relationship, Drug; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Muscle Contraction; Neuromuscular Junction; Time Factors; Vecuronium Bromide | 1987 |
Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
Topics: Adolescent; Adult; Atracurium; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neuromuscular Junction; Pancuronium; Vecuronium Bromide | 1987 |
Atracurium in patients with renal failure. Clinical trial of a new neuromuscular blocker.
Topics: Adult; Atracurium; Clinical Trials as Topic; Humans; Isoquinolines; Kidney Failure, Chronic; Middle Aged; Muscle Contraction; Neuromuscular Blocking Agents; Time Factors | 1986 |
17 other study(ies) available for atracurium and Chronic Kidney Failure
| Article | Year |
|---|---|
A comparison of the efficacy of cisatracurium and atracurium in kidney transplantation operation.
Topics: Adult; Anesthesia; Atracurium; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neuromuscular Blocking Agents; Treatment Outcome | 2004 |
Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Atracurium; Blood Pressure; Female; Heart Rate; Humans; Intubation, Intratracheal; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Tubocurarine; Vecuronium Bromide | 1984 |
[Muscle relaxant effect of atracurium in patients with chronic renal failure].
Topics: Adult; Atracurium; Electric Stimulation; Female; Humans; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Time Factors | 1984 |
The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure.
Topics: Anesthesia, General; Atracurium; Chromatography, Ion Exchange; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Models, Biological; Muscle Contraction; Neuromuscular Nondepolarizing Agents | 1984 |
Use of the muscle relaxant atracurium in anephric patients: preliminary communication.
Topics: Adjuvants, Anesthesia; Adult; Atracurium; Humans; Isoquinolines; Kidney Failure, Chronic; Middle Aged; Neuromuscular Blocking Agents; Neuromuscular Junction; Synaptic Transmission | 1982 |
Use of atracurium in patients with no renal function.
Topics: Adult; Atracurium; Electric Stimulation; Female; Humans; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Monitoring, Physiologic; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Surgical Procedures, Operative; Time Factors | 1982 |
Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure.
Topics: Adult; Age Factors; Atracurium; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Neuromuscular Nondepolarizing Agents; Sex Factors; Stereoisomerism | 1995 |
Pharmacokinetics of 51W89: preliminary data.
Topics: Atracurium; Half-Life; Humans; Isomerism; Isoquinolines; Kidney; Kidney Failure, Chronic; Metabolic Clearance Rate; Neuromuscular Nondepolarizing Agents; Opium; Renal Dialysis | 1995 |
[The use of atracurium besylate (Tracrium) in patients undergoing kidney transplantation].
Topics: Anesthetics, Intravenous; Atracurium; Humans; Kidney Failure, Chronic; Kidney Transplantation; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Preanesthetic Medication; Propofol; Thiopental; Time Factors | 1997 |
[Prolonged post-anesthesia recovery in hemodialysis-induced hypothyroidism].
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Inhalation; Atracurium; Clorazepate Dipotassium; Female; GABA Modulators; Humans; Hypothyroidism; Kidney Failure, Chronic; Kidney Transplantation; Neuromuscular Nondepolarizing Agents; Renal Dialysis; Thyroxine | 1998 |
Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end-stage renal failure.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Atracurium; Female; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neuromuscular Blocking Agents; Piperidines; Propofol; Remifentanil | 1999 |
[The use of atracurium in patients with chronic renal insufficiency].
Topics: Atracurium; Humans; Kidney Failure, Chronic | 1990 |
[Metabolism and pharmacokinetics of atracurium].
Topics: Acidosis; Atracurium; Humans; Hypothermia; Isoquinolines; Kidney Failure, Chronic; Kinetics; Liver Diseases; Neuromuscular Nondepolarizing Agents; Tubocurarine | 1985 |
[Atracurium requirement in surgical patients with normally functioning kidneys and in those with terminal renal failure].
Topics: Adolescent; Adult; Anesthesia, General; Atracurium; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Surgical Procedures, Operative | 1987 |
Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.
Topics: Adult; Aged; Alcohols; Atracurium; Female; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Male; Mathematics; Middle Aged; Models, Biological | 1987 |
Pharmacokinetics of atracurium and its metabolites.
Topics: Atracurium; Chronic Disease; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Liver Diseases; Metabolic Clearance Rate; Neuromuscular Blocking Agents | 1986 |
Effect of renal failure on laudanosine excretion in man.
Topics: Atracurium; Humans; Isoquinolines; Kidney Failure, Chronic; Neuromuscular Blocking Agents; Time Factors | 1985 |